1. Home
  2. CCTG vs MRKR Comparison

CCTG vs MRKR Comparison

Compare CCTG & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCTG
  • MRKR
  • Stock Information
  • Founded
  • CCTG 1993
  • MRKR N/A
  • Country
  • CCTG Hong Kong
  • MRKR United States
  • Employees
  • CCTG N/A
  • MRKR N/A
  • Industry
  • CCTG
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCTG
  • MRKR Health Care
  • Exchange
  • CCTG Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • CCTG 14.9M
  • MRKR 13.4M
  • IPO Year
  • CCTG 2024
  • MRKR N/A
  • Fundamental
  • Price
  • CCTG $1.22
  • MRKR $1.12
  • Analyst Decision
  • CCTG
  • MRKR Strong Buy
  • Analyst Count
  • CCTG 0
  • MRKR 3
  • Target Price
  • CCTG N/A
  • MRKR $13.17
  • AVG Volume (30 Days)
  • CCTG 13.3K
  • MRKR 39.8K
  • Earning Date
  • CCTG 12-27-2024
  • MRKR 05-27-2025
  • Dividend Yield
  • CCTG N/A
  • MRKR N/A
  • EPS Growth
  • CCTG N/A
  • MRKR N/A
  • EPS
  • CCTG N/A
  • MRKR N/A
  • Revenue
  • CCTG $16,463,490.00
  • MRKR $6,591,080.00
  • Revenue This Year
  • CCTG N/A
  • MRKR N/A
  • Revenue Next Year
  • CCTG N/A
  • MRKR N/A
  • P/E Ratio
  • CCTG N/A
  • MRKR N/A
  • Revenue Growth
  • CCTG 3.27
  • MRKR 99.06
  • 52 Week Low
  • CCTG $1.16
  • MRKR $0.95
  • 52 Week High
  • CCTG $3.17
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • CCTG 41.06
  • MRKR 46.59
  • Support Level
  • CCTG $1.19
  • MRKR $1.09
  • Resistance Level
  • CCTG $1.28
  • MRKR $1.30
  • Average True Range (ATR)
  • CCTG 0.07
  • MRKR 0.08
  • MACD
  • CCTG 0.00
  • MRKR -0.00
  • Stochastic Oscillator
  • CCTG 44.00
  • MRKR 26.19

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: